That gave Takeda two major manufacturing plants in Germany – in the town of Singen in the south and near Berlin in the northeast. Both locations have a decades-long tradition of manufacturing medicine. Today, Takeda employs some 2,500 people in Germany. They specialize in the production of high-quality medication that reaches patients in more than 100 countries around the world. Takeda has expanded substantially in Germany in the past few years, investing more than EUR 300 million.
This money went toward increasing capacity at the Oranienburg plant by 50 percent in 2017, while the Singen plant is about to become Takeda’s first site to produce a dengue fever vaccine. Takeda’s production was not slowed by the coronavirus pandemic.